[HTML][HTML] Key role of poly-γ-dl-glutamic acid in immune evasion and virulence of Staphylococcus epidermidis

S Kocianova, C Vuong, Y Yao… - The Journal of …, 2005 - Am Soc Clin Investig
S Kocianova, C Vuong, Y Yao, JM Voyich, ER Fischer, FR DeLeo, M Otto
The Journal of clinical investigation, 2005Am Soc Clin Investig
Coagulase-negative staphylococci, with the leading species Staphylococcus epidermidis,
are the predominant cause of hospital-acquired infections. Treatment is especially difficult
owing to biofilm formation and frequent antibiotic resistance. However, virulence
mechanisms of these important opportunistic pathogens have remained poorly
characterized. Here we demonstrate that S. epidermidis secretes poly-γ-DL-glutamic acid
(PGA) to facilitate growth and survival in the human host. Importantly, PGA efficiently …
Coagulase-negative staphylococci, with the leading species Staphylococcus epidermidis, are the predominant cause of hospital-acquired infections. Treatment is especially difficult owing to biofilm formation and frequent antibiotic resistance. However, virulence mechanisms of these important opportunistic pathogens have remained poorly characterized. Here we demonstrate that S. epidermidis secretes poly-γ-DL-glutamic acid (PGA) to facilitate growth and survival in the human host. Importantly, PGA efficiently sheltered S. epidermidis from key components of innate host defense, namely antimicrobial peptides and neutrophil phagocytosis, and was indispensable for persistence during device-related infection. Furthermore, PGA protected S. epidermidis from high salt concentration, a key feature of its natural environment, the human skin. Notably, PGA was synthesized by all tested strains of S. epidermidis and a series of closely related coagulase-negative staphylococci, most of which are opportunistic pathogens. Our study presents important novel biological functions for PGA and indicates that PGA represents an excellent target for therapeutic maneuvers aimed at treating disease caused by S. epidermidis and related staphylococci.
The Journal of Clinical Investigation